A surface plasmon resonance-based assay to detect exosomes was utilized to report elevated levels of epithelial cell adhesion molecule (EpCAM) and CD24 in exosomes from ascites of ovarian cancer patients, indicating their use as a diagnostic and prognostic biomarker [42]. This evidence concerns the gene EPCAM and ovarian cancer.